A positive correlation has been identified between IL-38 and PD-1/PD-L1, suggesting that NSCLC patients with high IL-38 expression exhibit a higher TNM score and shorter disease-free survival, particularly in PD-L1-negative tumours where T cell activity is presumed to be less suppressed. The gene discussed is IL1F10; the disease is non-small cell lung carcinoma.